Trial Profile
Retrospective observational study of Romiplostim in adults and children with primary immune thrombocytopenia (pITP)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2015 New trial record